早期干预集束化治疗对急诊科潜伏性/显性脓毒性休克患者临床预后的影响
该回顾性研究纳入2018年1月至2019年12月复旦大学附属华山医院北院急诊科收治的181例潜伏性/显性脓毒性休克患者,潜伏性休克组102例、显性休克组79例,比较两组早期(3小时)干预集束化指标、6小时集束化依从率及28天预后。显性休克组28天死亡率31.65%高于潜伏性休克组15.69%,且入院乳酸更高、早期集束化依从率更高但稳定时间更长、6小时乳酸清除率更低。二元Logistic回归显示入院乳酸、6小时乳酸清除率、第3小时抗生素使用、第1小时快速液体复苏、6小时ScvO2依从率为28天死亡独立危险因素。ROC曲线显示入院乳酸对28天死亡预测价值最高(AUC 0.706),其次为6小时ScvO2依从率(AUC 0.673)。结论认为两类患者均需早期诊断和干预集束化治疗以改善预后。
要点
- 显性脓毒性休克患者28天死亡率为31.65%(25/79),高于潜伏性休克组的15.69%(16/102)。
- 死亡患者入院乳酸更高(7.59±2.27 vs. 5.92±1.24 mmol/L),6小时乳酸清除率更低(46.58±15.83% vs. 59.60±17.92%)。
- 二元Logistic回归显示入院乳酸(OR 1.618)、6小时乳酸清除率(OR 0.021)、第3小时抗生素使用(OR 0.100)、第1小时快速液体复苏(OR 0.307)、6小时ScvO2依从率(OR 3.018)为28天死亡独立危险因素(均P<0.05)。
- 入院乳酸对28天死亡预测价值最高(AUC 0.706),6小时ScvO2依从率次之(AUC 0.673)。
- 10例潜伏性休克患者入院24小时内进展为显性休克。
适用人群与场景
- 2018年1月至2019年12月复旦大学附属华山医院北院急诊科收治的潜伏性/显性脓毒性休克患者,共181例,其中潜伏性休克组102例、显性休克组79例。
诊断标准与关键阈值
- 原文未提及潜伏性/显性脓毒性休克的诊断标准或评分界值。
- 显性休克组所有患者均需使用血管活性药物维持平均动脉压(MAP)≥65 mmHg(1 mmHg=0.133 kPa)。
处置流程与药物剂量
- 早期(3小时)干预集束化治疗:第1小时快速液体复苏(晶体液或晶体液联合人血白蛋白)及血管活性药物使用;第1、2、3小时抗生素使用。
- 6小时集束化治疗达标指标包括:6小时乳酸清除率、6小时ScvO2依从率、6小时尿量依从率。
- 原文未提及具体药物剂量、液体用量、抗生素种类及疗程。
红旗征与不能漏的情况
- 潜伏性休克患者可能在24小时内进展为显性休克(原文10例),需密切监测。
- 入院乳酸升高、6小时乳酸清除率低、第3小时未使用抗生素、第1小时未快速液体复苏、6小时ScvO2依从率低提示28天死亡风险增高。
研究设计与关键结果
- 回顾性队列研究,单中心,纳入181例急诊科潜伏性/显性脓毒性休克患者(潜伏性组102例,显性组79例)。
- 显性休克组28天死亡率31.65%高于潜伏性休克组15.69%(P<0.05)。
- 与潜伏性休克组相比,显性休克组入院乳酸更高(7.09±2.08 vs. 5.69±1.27 mmol/L),6小时乳酸清除率更低(50.27±21.53% vs. 61.82±13.12%),稳定时间更长(4.40±1.35 vs. 1.49±0.55天),6小时ScvO2依从率更低(60.76% vs. 78.43%),均P<0.05。
- 死亡患者入院乳酸更高(7.59±2.27 vs. 5.92±1.24 mmol/L)、血管活性药物使用比例更高(65.85% vs. 44.29%),6小时乳酸清除率更低(46.58±15.83% vs. 59.60±17.92%),第3小时抗生素使用比例更低(4.88% vs. 24.29%),6小时尿量依从率更低(56.10% vs. 82.86%),6小时ScvO2依从率更低(43.90% vs. 78.57%),均P<0.05。
- 二元Logistic回归:入院乳酸OR 1.618、6小时乳酸清除率OR 0.021、第3小时抗生素使用OR 0.100、第1小时快速液体复苏OR 0.307、6小时ScvO2依从率OR 3.018,均为28天死亡独立危险因素(均P<0.05)。
- ROC曲线:入院乳酸AUC 0.706,6小时ScvO2依从率AUC 0.673。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限性:回顾性设计、单中心、样本量181例,原文未提及证据等级或推荐强度。
对床旁实践的改变
- 对急诊科潜伏性/显性脓毒性休克患者应尽早识别并启动早期干预集束化治疗。
- 应关注6小时乳酸清除率和6小时ScvO2达标率,以改善预后。
- 对入院乳酸高、第1小时未快速液体复苏、第3小时未使用抗生素、6小时ScvO2依从率低的患者需警惕死亡风险增高。
- 潜伏性休克患者需密切监测24小时内是否进展为显性休克。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To observe the effect of early intervention bundle on clinical prognosis of patients with latent/overt septic shock in emergency department and analyze the risk factors for mortality.
METHODS: Patients with latent and overt septic shock admitted to the North Hospital of Huashan Hospital Affiliated to Fudan University from January 2018 to December 2019 were retrospectively analyzed and divided into latent shock group and overt shock group. The gender, age, main infection site, the time of shock diagnosis, the indicators of early (3-hour) intervention bundle, 6-hour compliance rate of intervention bundle, the remission time and 28-day prognosis were observed. Logistic regression analysis was used to identify risk factors for 28-day mortality. Receiver operating characteristic (ROC) curve was used to analyze its prognostic value.
RESULTS: Totally 181 patients were included in the analysis. There were 102 cases in the latent shock group, and 28-day mortality was 15.69% (16 cases); 79 cases in the overt shock group, and 28-day mortality was 31.65% (25 cases). Compared with the latent shock group, patients in overt shock group had higher compliance rate of early intervention bundle (93.67% vs. 58.82%), higher blood lactate acid at admission [Lac (mmol/L): 7.09±2.08 vs. 5.69±1.27], higher compliance rate of blood culture before antibiotics (93.67% vs. 63.73%), higher proportion of antibiotics use at the first and second hours (45.57% vs. 31.37%, 54.43% vs. 33.33%), higher proportion of rapid fluid resuscitation at the first hour (crystal liquid: 59.49% vs. 11.76%, crystal fluid combined with human serum albumin: 40.51% vs. 0%), and higher proportion of vasoactive use at the first hour (100% vs. 9.80%). The stable time was significantly prolonged (days: 4.40±1.35 vs. 1.49±0.55), while the onset time (days: 1.47±0.97 vs. 2.95±1.61), the time of diagnosis (minutes: 31.30±12.54 vs. 79.15±13.81), 6-hour lactate clearance [(50.27±21.53)% vs. (61.82±13.12)%], the proportion of antibiotics use at the third hour (0% vs. 35.29%), the proportion of rapid fluid resuscitation at the second and third hour (second hour crystal liquid: 0% vs. 60.78%, second hour crystal fluid combined with human serum albumin: 0% vs. 14.71%, third hour crystal liquid: 0% vs. 12.75%), 6-hour compliance rate of the standard of central venous blood saturation (ScvO2, 60.76% vs. 78.43%) and the success rate of treatment (28-day mortality: 31.65% vs. 15.69%) were lower than those of the latent shock group (all P < 0.05). Ten patients with latent shock developed into overt shock within 24 hours after admission. All patients with overt shock needed vasoactive drugs to maintain mean arterial pressure (MAP) ≥ 65 mmHg (1 mmHg = 0.133 kPa). Compared with the survival patients, the Lac (mmol/L: 7.59±2.27 vs. 5.92±1.24) and the proportion of vasoactive drugs use (65.85% vs. 44.29%) were significantly increased in the death patients, while the 6-hour lactate clearance [(46.58±15.83)% vs. (59.60±17.92)%], the proportion of antibiotics use in the third hour (4.88% vs. 24.29%), and 6-hour compliance rate of urine volume and ScvO2 (56.10% vs. 82.86%, 43.90% vs. 78.57%) were significantly decreased (all P < 0.05). Binary Logistic regression analysis showed that Lac at admission, 6-hour lactate clearance, the use of antibiotics at the third hour, rapid fluid resuscitation at the first hour, and 6-hour compliance rate of ScvO2 were independent risk factors for 28-day mortality [odds ratio (OR) was 1.618, 0.021, 0.100, 0.307 and 3.018, all P < 0.05]. ROC curve analysis showed that the Lac at admission had the highest predictive value for 28-day mortality, the area under the ROC curve (AUC) was 0.706; followed by 6-hour compliance rate of ScvO2 (AUC was 0.673).
CONCLUSIONS: Patients with latent/overt septic shock need early diagnosis and intervention bundle to improve the 6-hour blood lactate clearance and 6-hour compliance rate of ScvO2 and reduce the mortality.
参考来源
- Liu A, Du Y, Ge Z, et al. [Effect of early intervention bundle on clinical prognosis of patients with latent/overt septic shock in emergency department]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33198860. doi:10.3760/cma.j.cn121430-20200930-00655
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。